Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With URL, Takeda Looks To Become U.S. Gout Therapy Provider Of Choice

Apr 11 2012

Related Content

Novartis' Ilaris For Gout: FDA Questions Whether Symptom Relief Is Worth Risks

Jun 17 2011

As Gout Market Opens Up, Experts Await Therapies To Better Lower Uric Acid

Nov 01 2009

Hill Democrats Continue Inquiries Into High Prices For New Versions Of Old Drugs; Avanir's Nuedexta And URL Pharma's Colcrys Targeted

May 25 2011

Regeneron’s Arcalyst Gets Advisory Committee For Niche Gout Indication

Mar 07 2012

Colcrys Promo Eats Pavement As FDA Objects To Ad Of Motorcyclist Holding Teacup

Jan 12 2012

Related Companies

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Savient Pharmaceuticals, Inc.

Novartis AG

Regeneron Pharmaceuticals, Inc.

Additional Topics

United States Deals BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window